Reports Corner

South Korea Biosimilar Market Analysis

RC
Description
Description
South Korea has emerged as one of the strategic location for the
development of biosimilars on the...
Brief Summary
Brief Summary
South Korea has emerged as one of the strategic location for the
development of biosimilars on...
Brief Summary
Brief Summary
Thus, with all the government policies and frameworks, the
biosimilars market in South Korea h...
Brief Summary
Brief Summary
“South Korea Biosimilar Market Analysis” reports gives
comprehensive details on following aspe...
Table of Contents
Table of Contents
1. South Korea Biosimilar Market Overview
1.1 Current Market Scenario
1.2 Favorable Ma...
Table of Contents
Table of Contents
3. Agreement & Partnership for Development of Biosimilars
3.1 Samsung Biologics & Biog...
Table of Contents
Table of Contents
6. Regulation for Evaluation of Biosimilars in South Korea
6.1 Terminology
6.2 Selecti...
Table of Contents
Table of Contents
6.5.5 Safety
6.5.6 Immunogenicity
6.5.7 Extrapolation To Other Clinical Indications
7....
For more information
For more information
For more information please visit our website
https://www.reportscorner.com/repo...
RC

Thank You
Thank You

Contact us: contact@reportscorner.com
www.reportscorner.com

Reports Corner
Upcoming SlideShare
Loading in …5
×

South korea biosimilar market analysis - ReportsCorner

690 views
538 views

Published on

South Korea has emerged as one of the strategic location for the development of biosimilars on the global level. Among the various emerging countries identified for development of biosimilars, South Korea is one of the most promising countries where pharmaceutical companies have identified huge investment potentials for the drug development process. One of the major reasons for the attractiveness of South Korea is the end of patent protection for some blockbuster drugs in the coming years and the need for novel therapeutics.

https://www.reportscorner.com/reports/35202/South-Korea-Biosimilar-Market-Analysis/

Published in: News & Politics
0 Comments
0 Likes
Statistics
Notes
  • Be the first to comment

  • Be the first to like this

No Downloads
Views
Total views
690
On SlideShare
0
From Embeds
0
Number of Embeds
0
Actions
Shares
0
Downloads
9
Comments
0
Likes
0
Embeds 0
No embeds

No notes for slide

South korea biosimilar market analysis - ReportsCorner

  1. 1. Reports Corner South Korea Biosimilar Market Analysis RC
  2. 2. Description Description South Korea has emerged as one of the strategic location for the development of biosimilars on the global level. Among the various emerging countries identified for development of biosimilars, South Korea is one of the most promising countries where pharmaceutical companies have identified huge investment potentials for the drug development process. One of the major reasons for the attractiveness of South Korea is the end of patent protection for some blockbuster drugs in the coming years and the need for novel therapeutics. www.reportscorner.com Reports Corner
  3. 3. Brief Summary Brief Summary South Korea has emerged as one of the strategic location for the development of biosimilars on the global level. Among the various emerging countries identified for development of biosimilars, South Korea is one of the most promising countries where pharmaceutical companies have identified huge investment potentials for the drug development process. One of the major reasons for the attractiveness of South Korea is the end of patent protection for some blockbuster drugs in the coming years and the need for novel therapeutics. Offering the advantages of favorable government and business conducive environment, the South Korean biosimilars market is poised for significant and rapid growth in the future years. There are many favorable steps undertaken by the government in this regard, some of them being tax holidays, tax concessions, cash grant, site location support and financial support for pharmaceutical companies investing in Korea. www.reportscorner.com Reports Corner
  4. 4. Brief Summary Brief Summary Thus, with all the government policies and frameworks, the biosimilars market in South Korea has become the growth engine of the country attracting huge investments from public and private companies located in and outside Korea. The South Korean Government has announced its plans to promote the biosimilars industry and make huge investments in the industry so as to make Korea a dominant player in the global marketplace. At present, the share of South Korea in the global biosimilars development is extremely meager. However, with the aggressive government support, and the increasing focus on biosimilars development, the government aims that the country would occupy a significant share of the global market for biosimilars by 2020. www.reportscorner.com Reports Corner
  5. 5. Brief Summary Brief Summary “South Korea Biosimilar Market Analysis” reports gives comprehensive details on following aspects related to Biosimilar development in South Korea: * Market Overview * Favorable Market Parameters * Biosimilar Pipeline Analysis by Company, Phase & Disease * Regulation foe Development of Biosimilars * Emerging Market Trends * Competitive Landscape * Agreement & Partnership for Development of Biosimilars www.reportscorner.com Reports Corner
  6. 6. Table of Contents Table of Contents 1. South Korea Biosimilar Market Overview 1.1 Current Market Scenario 1.2 Favorable Market Dynamics for Development of Biosimilars 1.3 Challenges to be Resolved for Development of Biosimilars 2. South Korea Biosimilar Pipeline (Clinical Phase, Indication, Biochemical Class & Company) 2.1 Research 2.2 Preclinical 2.3 Phase-I 2.4 Phase-II 2.5 Phase-III 2.6 Preregistration 2.7 Registered 2.8 Marketed www.reportscorner.com Reports Corner
  7. 7. Table of Contents Table of Contents 3. Agreement & Partnership for Development of Biosimilars 3.1 Samsung Biologics & Biogen Idec 3.2 Merck & Hanwha Chemical Corporation 3.3 Meiji Seika Pharma and Dong-A Pharmaceutical 3.4 Pharmascience and Korea Kolmar Holdings 4. Emerging Trends 4.1 Government Investments in the Biosimilar Development 4.2 Approval of first Biosimilar Drug of Arthritis Medicine by KFDA 4.3 Local Firms Dominating the Biosimilar R&D 4.4 Rising Bio Industry Exports 5. South Korea Biosimilar Market Future Outlook 5.1 Domestic Market Opportunity 5.2 Contract Manufacturing Opportunity www.reportscorner.com Reports Corner
  8. 8. Table of Contents Table of Contents 6. Regulation for Evaluation of Biosimilars in South Korea 6.1 Terminology 6.2 Selection Of Reference Product 6.3 Evaluation of Quality 6.3.1 Manufacturing Process 6.3.2 Comparability Studies For Quality Evaluation 6.3.3 Specifications 6.3.4 Analytical Procedures 6.3.5 Stability Studies 6.4 Non-Clinical Evaluation 6.5 Clinical Evaluation 6.5.1 Pharmacokinetic Studies 6.5.2 Pharmacodynamic Studies 6.5.3 Efficacy Studies 6.5.4 Confirmatory Pharmacokinetic / Pharmacodynamic Studies www.reportscorner.com Reports Corner
  9. 9. Table of Contents Table of Contents 6.5.5 Safety 6.5.6 Immunogenicity 6.5.7 Extrapolation To Other Clinical Indications 7. Competitive Landscape 7.1 Samsung Biologics 7.2 Celltrion 7.3 Dong-A Pharm 7.4 LG life Sciences 7.5 ISU Abxis www.reportscorner.com Reports Corner
  10. 10. For more information For more information For more information please visit our website https://www.reportscorner.com/reports/35202/South-Korea-Biosimilar-MarketAnalysis/ www.reportscorner.com Reports Corner
  11. 11. RC Thank You Thank You Contact us: contact@reportscorner.com www.reportscorner.com Reports Corner

×